x

Registration Form

Required.

Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy.

This webinar is for Health Care Professionals only. Upon submitting this registration, I am confirming that I am a Health Care Professional.

Significant blood pressure-banner new
2023 ESH HPTN
2023 ESH HPTN

aUse of Diuretics:–Consider transition to Loop Diuretic if eGFR is between 30 to 45 ml/min/1.73 m2–If eGFR <30 ml/min/1.73 m2 use Loop Diuretic,
bBB should be used as guideline directed medical therapy in respective indications or considered in several other conditions,  
cControlled below 140/90  mmHg,  
dWhen SBP is ≥140 mmHg or DBP is ≥90 mmHg provided that:–maximum recommended and tolerated doses of a three-drug combination comprising 
a RAS blocker (either an ACEi or an ARB), a CCB and a Thiazide/Thiazide-like diuretic were used–adequate BP control has been confirmed by ABPM or by HBPM if ABPM is not feasible–various causes of pseudo-resistant hypertension (especially poor medication adherence) and secondary hypertension have been excluded

   Footnotes
  • 1. SPC: single pill combination; HPTN: hypertension.
    2. Giuseppe M., et al. Journal of Hypertension 41(12):1874-2071, December 2023.
 scan-image
Scan QR code to access to Twynsta
prescribing information